Is the societal perspective in cost-effectiveness analysis useful for decision makers?

[1]  J. Eisenberg,et al.  Are we ready to use cost-effectiveness analysis in health care decision-making? A health services research challenge for clinicians, patients, health care systems, and public policy. , 1998, Medical care.

[2]  V. Hasselblad,et al.  Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. , 1997, JAMA.

[3]  M. Weinstein,et al.  Methods of cost-effectiveness analysis in the assessment of new drugs for Alzheimer's disease. , 1997, Psychiatric services.

[4]  M F Drummond,et al.  Users' Guides to the Medical Literature: XIII. How to Use an Article on Economic Analysis of Clinical Practice A. Are the Results of the Study Valid? , 1997 .

[5]  M. Gold.  Cost-effectiveness in health and medicine , 2016 .

[6]  Milton C. Weinstein,et al.  Recommendations for Reporting Cost-effectiveness Analyses , 1996 .

[7]  M C Weinstein,et al.  Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. , 1996, JAMA.

[8]  M. Weinstein,et al.  Recommendations of the Panel on Cost-effectiveness in Health and Medicine. , 1996, JAMA.

[9]  M. Weinstein,et al.  The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. , 1996, JAMA.

[10]  N. Powe,et al.  Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis. , 1996, JAMA.

[11]  Gordon B. Hazen,et al.  A Cost-effectiveness Analysis of Total Hip Arthroplasty for Osteoarthritis of the Hip , 1996 .

[12]  S. Solomon,et al.  School-based screening for tuberculous infection. A cost-benefit analysis. , 1995, JAMA.

[13]  M. Halloran,et al.  Cost-effectiveness of a routine varicella vaccination program for US children. , 1994, JAMA.

[14]  G A Colditz,et al.  Cost-Effectiveness and Cost-Benefit Analyses in the Medical Literature , 1992, Annals of Internal Medicine.

[15]  F. Sonnenberg,et al.  Myocardial revascularization for chronic stable angina. Analysis of the role of percutaneous transluminal coronary angioplasty based on data available in 1989. , 1990, Annals of internal medicine.

[16]  G. Oster,et al.  Cost-effectiveness of antihyperlipemic therapy in the prevention of coronary heart disease. The case of cholestyramine. , 1987, JAMA.